Increases in phospho-eIF2α levels occur in brains of sporadic AD and advanced pathological stages of APP transgenic mice including the 5XFAD model [24-26,45,46] and are shown to correlate with BACE1 elevation [25,26]. The gene discussed is EIF2A; the disease is Alzheimer disease.